These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 38658742)

  • 41. Synthesis and biological activity of trans-tiliroside derivatives as potent anti-diabetic agents.
    Zhu Y; Zhang Y; Liu Y; Chu H; Duan H
    Molecules; 2010 Dec; 15(12):9174-83. PubMed ID: 21150832
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Design, synthesis and biological evaluation of novel thiazol-2-yl benzamide derivatives as glucokinase activators.
    Charaya N; Pandita D; Grewal AS; Lather V
    Comput Biol Chem; 2018 Apr; 73():221-229. PubMed ID: 29518630
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A specific gut microbiota and metabolomic profiles shifts related to antidiabetic action: The similar and complementary antidiabetic properties of type 3 resistant starch from Canna edulis and metformin.
    Zhang C; Ma S; Wu J; Luo L; Qiao S; Li R; Xu W; Wang N; Zhao B; Wang X; Zhang Y; Wang X
    Pharmacol Res; 2020 Sep; 159():104985. PubMed ID: 32504839
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hypoglycemic effect and mechanism of honokiol on type 2 diabetic mice.
    Sun J; Fu X; Liu Y; Wang Y; Huo B; Guo Y; Gao X; Li W; Hu X
    Drug Des Devel Ther; 2015; 9():6327-42. PubMed ID: 26674084
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Long-term safety and efficacy of imeglimin as monotherapy or in combination with existing antidiabetic agents in Japanese patients with type 2 diabetes (TIMES 2): A 52-week, open-label, multicentre phase 3 trial.
    Dubourg J; Fouqueray P; Quinslot D; Grouin JM; Kaku K
    Diabetes Obes Metab; 2022 Apr; 24(4):609-619. PubMed ID: 34866306
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A comparison of the effects of thiazolidinediones and metformin on metabolic control in patients with type 2 diabetes mellitus.
    Seufert J; Lübben G; Dietrich K; Bates PC
    Clin Ther; 2004 Jun; 26(6):805-18. PubMed ID: 15262452
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Combination of Rheum ribes and Metformin Against Diabetes, Thermal Hyperalgesia, and Tactile Allodynia in a Mice Model.
    Raafat K; El-Lakany A
    Altern Ther Health Med; 2018 Sep; 24(5):33-43. PubMed ID: 28987074
    [TBL] [Abstract][Full Text] [Related]  

  • 48. An investigation of saliva and plasma levels of urotensin 2 in recently diagnosed type 2 diabetes mellitus patients on metformin treatment.
    Gozel N; Oral K; Ozdemir FA; Onalan E; Kuloglu T; Aydın S; Karataş A; Kılınç F
    Endokrynol Pol; 2020; 71(3):249-255. PubMed ID: 32293703
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Swietenine potentiates the antihyperglycemic and antioxidant activity of Metformin in Streptozotocin induced diabetic rats.
    Shiming Z; Mak KK; Balijepalli MK; Chakravarthi S; Pichika MR
    Biomed Pharmacother; 2021 Jul; 139():111576. PubMed ID: 33862494
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Assessment of In Vitro Tests as Predictors of the Antioxidant Effects of Insulin, Metformin, and Taurine in the Brain of Diabetic Rats.
    Clark GJ; Pandya K; Lau-Cam CA
    Adv Exp Med Biol; 2022; 1370():243-256. PubMed ID: 35882800
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Design, synthesis, docking and biological evaluation of chalcones as promising antidiabetic agents.
    Rammohan A; Bhaskar BV; Venkateswarlu N; Gu W; Zyryanov GV
    Bioorg Chem; 2020 Jan; 95():103527. PubMed ID: 31911298
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Novel hybrids of benzothiazole-1,3,4-oxadiazole-4-thiazolidinone: Synthesis, in silico ADME study, molecular docking and in vivo anti-diabetic assessment.
    Bhutani R; Pathak DP; Kapoor G; Husain A; Iqbal MA
    Bioorg Chem; 2019 Mar; 83():6-19. PubMed ID: 30339863
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Integrated fragment-based drug design and virtual screening techniques for exploring the antidiabetic potential of thiazolidine-2,4-diones: Design, synthesis and in vivo studies.
    Gupta S; Baweja GS; Singh S; Irani M; Singh R; Asati V
    Eur J Med Chem; 2023 Dec; 261():115826. PubMed ID: 37793328
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The mechanism by which imeglimin inhibits gluconeogenesis in rat liver cells.
    Vial G; Lamarche F; Cottet-Rousselle C; Hallakou-Bozec S; Borel AL; Fontaine E
    Endocrinol Diabetes Metab; 2021 Apr; 4(2):e00211. PubMed ID: 33855213
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Exploring the Dual Inhibitory Activity of Novel Anthranilic Acid Derivatives towards α-Glucosidase and Glycogen Phosphorylase Antidiabetic Targets: Design, In Vitro Enzyme Assay, and Docking Studies.
    Ihmaid S
    Molecules; 2018 May; 23(6):. PubMed ID: 29844263
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Synthesis and molecular docking of N'-arylidene-5-(4-chlorophenyl)-1-(3,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carbohydrazides as novel hypoglycemic and antioxidant dual agents.
    Hernández-Vázquez E; Salgado-Barrera S; Ramírez-Espinosa JJ; Estrada-Soto S; Hernández-Luis F
    Bioorg Med Chem; 2016 May; 24(10):2298-306. PubMed ID: 27079123
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Phase 2 trial with imeglimin in patients with Type 2 diabetes indicates effects on insulin secretion and sensitivity.
    Theurey P; Thang C; Pirags V; Mari A; Pacini G; Bolze S; Hallakou-Bozec S; Fouqueray P
    Endocrinol Diabetes Metab; 2022 Nov; 5(6):e371. PubMed ID: 36239048
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Discovery of new dual PPARγ-GPR40 agonists with robust antidiabetic activity: Design, synthesis and in combo drug evaluation.
    Hidalgo-Figueroa S; Navarrete-Vázquez G; Estrada-Soto S; Giles-Rivas D; Alarcón-Aguilar FJ; León-Rivera I; Giacoman-Martínez A; Miranda Pérez E; Almanza-Pérez JC
    Biomed Pharmacother; 2017 Jun; 90():53-61. PubMed ID: 28342366
    [TBL] [Abstract][Full Text] [Related]  

  • 59. In silico and in vivo analysis to identify the antidiabetic activity of beta sitosterol in adipose tissue of high fat diet and sucrose induced type-2 diabetic experimental rats.
    Ponnulakshmi R; Shyamaladevi B; Vijayalakshmi P; Selvaraj J
    Toxicol Mech Methods; 2019 May; 29(4):276-290. PubMed ID: 30461321
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Synthesis of 6-chloro-2-Aryl-1H-imidazo[4,5-b]pyridine derivatives: Antidiabetic, antioxidant, β-glucuronidase inhibiton and their molecular docking studies.
    Taha M; Ismail NH; Imran S; Rashwan H; Jamil W; Ali S; Kashif SM; Rahim F; Salar U; Khan KM
    Bioorg Chem; 2016 Apr; 65():48-56. PubMed ID: 26855413
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.